210 related articles for article (PubMed ID: 19678764)
1. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy.
Garvey LJ; Yerrakalva D; Winston A
AIDS Res Hum Retroviruses; 2009 Aug; 25(8):765-9. PubMed ID: 19678764
[TBL] [Abstract][Full Text] [Related]
2. Cerebral function tests reveal differences in HIV-infected subjects with and without chronic HCV co-infection.
Thiyagarajan A; Garvey LJ; Pflugrad H; Maruff P; Scullard G; Main J; Taylor-Robsinson S; Winston A
Clin Microbiol Infect; 2010 Oct; 16(10):1579-84. PubMed ID: 20132257
[TBL] [Abstract][Full Text] [Related]
3. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy.
Garvey L; Surendrakumar V; Winston A
HIV Clin Trials; 2011; 12(6):333-8. PubMed ID: 22189152
[TBL] [Abstract][Full Text] [Related]
4. Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients.
Ciccarelli N; Grima P; Fabbiani M; Baldonero E; Borghetti A; Milanini B; Limiti S; Colafigli M; Tamburrini E; Cauda R; De Luca A; Di Giambenedetto S
Antivir Ther; 2015; 20(4):433-40. PubMed ID: 25504667
[TBL] [Abstract][Full Text] [Related]
5. Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia.
Ciccarelli N; Fabbiani M; Colafigli M; Trecarichi EM; Silveri MC; Cauda R; Murri R; De Luca A; Di Giambenedetto S
Antivir Ther; 2013; 18(2):153-60. PubMed ID: 23486721
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.
Tozzi V; Balestra P; Murri R; Galgani S; Bellagamba R; Narciso P; Antinori A; Giulianelli M; Tosi G; Fantoni M; Sampaolesi A; Noto P; Ippolito G; Wu AW
Int J STD AIDS; 2004 Apr; 15(4):254-9. PubMed ID: 15075020
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus.
Guevara-Silva EA
Neurologia; 2014 May; 29(4):224-9. PubMed ID: 23972623
[TBL] [Abstract][Full Text] [Related]
8. Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controls.
Ashby J; Foster C; Garvey L; Wan T; Allsop J; Paramesparan Y; Taylor-Robinson SD; Fidler S; Winston A
HIV Clin Trials; 2015; 16(2):81-7. PubMed ID: 25874990
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.
Fabbiani M; Grima P; Milanini B; Mondi A; Baldonero E; Ciccarelli N; Cauda R; Silveri MC; De Luca A; Di Giambenedetto S
Antivir Ther; 2015; 20(4):441-7. PubMed ID: 25516553
[TBL] [Abstract][Full Text] [Related]
11. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.
Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK;
AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495
[TBL] [Abstract][Full Text] [Related]
12. Better quality of life with neuropsychological improvement on HAART.
Parsons TD; Braaten AJ; Hall CD; Robertson KR
Health Qual Life Outcomes; 2006 Feb; 4():11. PubMed ID: 16504114
[TBL] [Abstract][Full Text] [Related]
13. Depression and neurocognitive performance in Portuguese patients infected with HIV.
Bragança M; Palha A
AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031
[TBL] [Abstract][Full Text] [Related]
14. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F
Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784
[TBL] [Abstract][Full Text] [Related]
15. Cognitive disorders in HIV-infected patients: are they HIV-related?
Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive functioning of HIV positive children attending the comprehensive care clinic at Kenyatta national hospital: exploring neurocognitive deficits and psychosocial risk factors.
Musindo O; Bangirana P; Kigamwa P; Okoth R; Kumar M
AIDS Care; 2018 May; 30(5):618-622. PubMed ID: 29353495
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.
Royal W; Cherner M; Carr J; Habib AG; Akomolafe A; Abimiku A; Charurat M; Farley J; Oluyemisi A; Mamadu I; Johnson J; Ellis R; McCutchan JA; Grant I; Blattner WA
J Neurovirol; 2012 Jun; 18(3):191-9. PubMed ID: 22528480
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy.
Shanbhag MC; Rutstein RM; Zaoutis T; Zhao H; Chao D; Radcliffe J
Arch Pediatr Adolesc Med; 2005 Jul; 159(7):651-6. PubMed ID: 15996999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
